Publication | Open Access

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation

Molecular PharmacologyNeurodegenerative DiseasesDrug TargetAlzheimer's DiseaseNovel Multi-target-directed LigandsMedicineReceptor AntagonistsPharmacological AgentNeuropharmacologyNeurologyNon-peptide LigandCombining Cholinesterase InhibitorsPharmacologyDrug Discovery